Basilea Pharmaceutica AG (SWX: BSLN)
Switzerland
· Delayed Price · Currency is CHF 45.40
-0.15 (-0.33%)
Sep 4, 2024, 5:30 PM CET
Basilea Pharmaceutica AG Cash Flow Statement
Financials in millions CHF. Fiscal year is January - December.
Millions CHF. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2015 |
| Net Income | -8.89 | -13.73 | -14.6 | -7.54 | -11.52 | -11.25 | Upgrade
|
| Depreciation & Amortization | 2.55 | 2.7 | 2.75 | 2.81 | 2.63 | 2.71 | Upgrade
|
| Other Amortization | 0.06 | 0.05 | 0.09 | 0.07 | 0.04 | 0 | Upgrade
|
| Asset Writedown & Restructuring Costs | 4.42 | 4.54 | 3.6 | - | - | - | Upgrade
|
| Stock-Based Compensation | 3.73 | 0.92 | 1.03 | 0.39 | 0.75 | 0.5 | Upgrade
|
| Other Operating Activities | -1.4 | 0.23 | 1.05 | -0.99 | -0.41 | -1.42 | Upgrade
|
| Change in Accounts Receivable | -5.75 | -4.57 | -1.64 | -0.74 | -0.38 | -0.48 | Upgrade
|
| Change in Inventory | -2.47 | -2.48 | -1.59 | -0.34 | -0.52 | -0.47 | Upgrade
|
| Change in Accounts Payable | 1.64 | 0.06 | 0.49 | - | - | - | Upgrade
|
| Change in Other Net Operating Assets | 3.69 | 3.45 | 1.47 | 0.88 | 0.16 | -0.45 | Upgrade
|
| Operating Cash Flow | -2.42 | -8.84 | -7.35 | -5.46 | -9.24 | -10.85 | Upgrade
|
| Capital Expenditures | -0.83 | -0.32 | -0.39 | -0.3 | -0.06 | -0.09 | Upgrade
|
| Sale (Purchase) of Intangibles | -0.02 | -0.01 | -0.01 | -0.07 | -0.16 | -0.03 | Upgrade
|
| Investing Cash Flow | -0.85 | -0.33 | -0.4 | -0.37 | -0.22 | -0.12 | Upgrade
|
| Short-Term Debt Issued | - | - | - | 6.4 | 0.1 | - | Upgrade
|
| Total Debt Issued | - | - | - | 6.4 | 0.1 | - | Upgrade
|
| Short-Term Debt Repaid | - | - | -2.37 | - | - | - | Upgrade
|
| Long-Term Debt Repaid | - | -0.67 | -0.34 | -0.32 | -0.27 | -0.22 | Upgrade
|
| Total Debt Repaid | -0.66 | -0.67 | -2.72 | -0.32 | -0.27 | -0.22 | Upgrade
|
| Net Debt Issued (Repaid) | -0.66 | -0.67 | -2.72 | 6.08 | -0.17 | -0.22 | Upgrade
|
| Issuance of Common Stock | 1.33 | 0.5 | 6 | - | 18.62 | 14.3 | Upgrade
|
| Other Financing Activities | - | - | -0.06 | - | -1.37 | -0.96 | Upgrade
|
| Financing Cash Flow | 0.67 | -0.17 | 3.22 | 6.08 | 17.08 | 13.13 | Upgrade
|
| Foreign Exchange Rate Adjustments | 0.01 | -0.52 | -0.03 | -0.01 | -0.03 | 0.31 | Upgrade
|
| Miscellaneous Cash Flow Adjustments | 0 | - | - | - | - | - | Upgrade
|
| Net Cash Flow | -2.58 | -9.86 | -4.56 | 0.24 | 7.59 | 2.47 | Upgrade
|
| Free Cash Flow | -3.25 | -9.16 | -7.74 | -5.76 | -9.3 | -10.93 | Upgrade
|
| Free Cash Flow Margin | -6.18% | -27.29% | -43.04% | -41.72% | -230.26% | -426.94% | Upgrade
|
| Free Cash Flow Per Share | -0.11 | -0.25 | -0.23 | -0.18 | -0.38 | -0.69 | Upgrade
|
| Cash Interest Paid | 0.05 | 0.06 | 0.08 | 0.12 | 0.08 | 0.02 | Upgrade
|
| Cash Income Tax Paid | 1.15 | 0.55 | 0 | 0.05 | 0 | 0.09 | Upgrade
|
| Levered Free Cash Flow | -6.04 | -7.29 | -4.55 | 5.24 | -7.6 | -6.12 | Upgrade
|
| Unlevered Free Cash Flow | -6.04 | -7.29 | -4.55 | 6.1 | -7.07 | -5.71 | Upgrade
|
| Change in Net Working Capital | 8.61 | 5.22 | 1.86 | -8.69 | 2.91 | 1.68 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.